Immunovant Inc (NASDAQ:IMVT) price on Thursday, April 10, fall -0.74% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $14.79.
A look at the stock’s price movement, the close in the last trading session was $14.90, moving within a range at $13.51 and $15.37. The beta value (5-Year monthly) was 0.808. Turning to its 52-week performance, $34.47 and $12.72 were the 52-week high and 52-week low respectively. Overall, IMVT moved -22.65% over the past month.
Immunovant Inc’s market cap currently stands at around $2.51 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-May-29.
Turning to the stock’s technical picture we see that short term indicators suggest on average that IMVT is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
20 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 6 analyst(s) rate the stock as a Hold, 13 recommend IMVT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 1 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
IMVT’s current price about -14.43% and -22.24% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 37.13, while 7-day volatility ratio is 14.25% and 9.20% in the 30-day chart. Further, Immunovant Inc (IMVT) has a beta value of 0.78, and an average true range (ATR) of 1.49. Analysts have given the company’s stock an average 52-week price target of $49, forecast between a low of $5 and high of $57. Looking at the price targets, the low is 66.19% off current price level while to achieve the yearly target high, price needs to move -285.4%. Nonetheless, investors will most likely welcome a -231.3% jump to $49 which is the analysts’ median price.
If we refocus on Immunovant Inc (NASDAQ:IMVT), historical trading data shows that trading volumes averaged 2.89 over the past 10 days and 1.75 million over the past 3 months. The company’s latest data on shares outstanding shows there are 147.20 million shares.
The 59.82% of Immunovant Inc’s shares are in the hands of company insiders while institutional holders own 49.43% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 15.8 million on 2025-03-14, giving us a short ratio of 14.8. The data shows that as of 2025-03-14 short interest in Immunovant Inc (IMVT) stood at 1805.9998999999998 of shares outstanding, with shares short rising to 14.79 million registered in 2025-02-14. Current price change has pushed the stock -40.29% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the IMVT stock continues to rise going into the next quarter.
